FUJIFILM Medical Systems U.S.A. introduced the ASPIRE Bellus II, its latest mammography diagnostic workstation, at the National Consortium of Breast Centers (NCoBCC) held in March in Las Vegas. The system has received U.S. Food and Drug Administration (FDA) 510(k) clearance and will begin shipping to customers in second quarter 2018.
The ASPIRE Bellus II offers a multimodality view for radiologists in high resolution display as well as the ability to compare two-dimensional (2D) and tomosynthesis images. It incorporates key diagnostic features such as current and prior image comparison, quadrant view, tomosynthesis support, and invert. The workstation enables customization for reading protocols and personalized configuration.Back To Top
New Fuji multimodality mammography workstation makes debut at NCoBCC. Appl Radiol.